Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Finally, future directions, gaps in the field and opportunities to control the course of neurological diseases by targeting the BBB are presented
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
To monitor the intracellular GSH and -GC amounts, cells were harvested and washed with distilled water
We found that Gclc deficiency increased m in mutant FoB compared to controls (Fig
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
